• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Melissa B. Gilkey, PhD

Latest:

Preventive Drug Lists as Tools for Managing Asthma Medication Costs

Findings of this qualitative interview study suggest promise, but also challenges, with regard to using preventive drug lists to help families manage asthma medication costs.




Eric M. Blau, MD

Latest:

A Telephone-Based Intervention for Increasing the Use of Osteoporosis Medication: A Randomized Controlled Trial

In this randomized controlled trial, women receiving monthly telephone calls had significantly higher use of osteoporosis medication at 1 year versus women receiving usual care.


Stacy B. Dale, MPA

Latest:

Patient Experience Midway Through a Large Primary Care Practice Transformation Initiative

Practice transformation toward comprehensive primary care slightly improved patient experience in 3 of 6 domains of care: access, provider support, and shared decision making.



Timothy K. Allen, PhD

Latest:

Measuring the Cost Implications of the Collaborative Accountable Care Initiative in Texas

A private accountable care organization model with an embedded care coordinator and a list of recommended providers yields cost savings similar to initiatives with risk-based contracts.



Michael Ciarametaro, MBA

Latest:

Good Health Policy Requires High-Quality Evidence. Let’s Remember That With Drug Pricing.

In the health spending debate, what policy makers need most is an honest, realistic, and evidence-based discussion. Unfortunately, many studies in the public arena fall far short.


Antoine Gosselin, MA

Latest:

Impact of Compliance With Proton Pump Inhibitors on NSAID Treatment

Patients with gastroesophageal reflux disease who are compliant with proton pump inhibitor therapy stay on NSAIDs longer than noncompliant patients.





Julie A. Patterson, BS

Latest:

Cost-Benefit of Appointment-Based Medication Synchronization in Community Pharmacies

This study conducted a cost-benefit analysis of appointment-based medication synchronization for improving adherence in patients on chronic medications for hypertension, hyperlipidemia, and diabetes.



Jianying Zhang, MD, MPH

Latest:

Behavioral Health Disorders and Adherence to Measures of Diabetes Care Quality

Persons with substance use disorders were less likely and persons with schizophrenia/paranoia were more likely to be adherent to measures of diabetes care quality.


Aaron S. Kesselheim, MD, JD, MPH

Latest:

US Spending on High-Revenue Rare Disease Drugs in 2022

One in 5 of the highest-revenue drugs of 2022 was exclusively approved for rare conditions, accounting for more than 7% of US pharmaceutical spending.



Christine Sawicki, RPh, MBA

Latest:

Provider and Patient Insights Into the Cancer Care Journey

A survey was conducted to determine opportunities to aid primary care providers and patients in the difficult journey of an oncology patient.



Lisa M. Nicolaou, RN, MSNI

Latest:

Quality Improvement and Leadership Capacity Development Through Lean Methodology

“Lean” methodology creates quality improvement and leadership capacity, which is currently missing in ambulatory care settings. Failure to create this capacity will minimize transformation efforts.


Sharon Fuller, BA

Latest:

Primary Care Physician Resource Use Changes Associated With Feedback Reports

Implementing systemwide dissemination of feedback reports to primary care physicians in an integrated delivery system may be associated with changes in medical resource use.




Sheryl L. Catz, PhD

Latest:

Improving BP Control Through Electronic Communications: An Economic Evaluation

Home blood pressure (BP) monitoring and use of secure webbased tools to manage care collaboratively with pharmacists is a cost-effective way to improve BP control.


Eric Helland, PhD

Latest:

Medicaid Prior Authorization Policies and Imprisonment Among Patients With Schizophrenia

This study examined the impact of prior authorization formularies on the likelihood that patients with schizophrenia will be arrested and incarcerated.





© 2026 MJH Life Sciences
AJMC®
All rights reserved.